Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Unfavorable clinical outcomes mean that cancer researchers must attempt to develop novel therapeutic strategies to overcome therapeutic resistance in patients with HNSCC. Recently, ferroptosis was shown to be a promising pathway possessing druggable targets, such as xCT (SLC7A11). Unfortunately, little is known about the molecular mechanisms underl...
Alternative Titles
Full title
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5acad250638b4b40b900a1921f5dba46
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5acad250638b4b40b900a1921f5dba46
Other Identifiers
ISSN
2073-4409
E-ISSN
2073-4409
DOI
10.3390/cells12020336
